CSHL organoid facility: Cancer custodians 7/2/2021 To beat our worst enemy, we must first let it grow. Read the story »
Research matters 6/8/2021 Innovative research and educational activities never stopped during the COVID-19 pandemic. Read the story »
Dr. David Tuveson inaugurated as AACR president 4/21/2021 CSHL Cancer Center Director David Tuveson is leading the American Association for Cancer Research. Read the story »
CSHL’s new organoid facility 11/5/2020 The 2,200 square foot facility will make and maintain hundreds of live tissue models grown from patient tumors. Read the story »
New genetic research to understand racial disparity in cancers 9/8/2020 Cold Spring Harbor Laboratory will study the genetic contributions of ethnicity to colon, endometrial, and pancreas cancers in African Americans. Read the story »
Live @ the Lab with David Tuveson: Studying pancreatic cancer 7/29/2020 Cold Spring Harbor Laboratory Cancer Center Director Dave Tuveson presents an exciting new model for studying pancreatic cancer. Watch the video »
The first mouse model of human pancreas cancer subtypes 7/23/2020 CSHL researchers discovered how slow-growing pancreatic tumors can switch into a more deadly sub-type. Read the story »
Applying symptom tracking to COVID-19 outpatient care using famotidine 6/4/2020 Researchers from CSHL and Northwell Health are developing a way to test promising COVID-19 drugs, like famotidine, by tracking outpatient symptoms. Read the story »
David Tuveson named President-Elect of AACR 4/21/2020 CSHL Cancer Center Director David Tuveson has been elected President-Elect of the American Association for Cancer Research. Read the story »
CSHL Cancer Center joins the AACI 1/10/2020 The CSHL Cancer Center becomes the 100th member of the Association of American Cancer Institutes. Read the story »
CSHL wins TD Ready Challenge grant for organoid facility 12/3/2019 CSHL is one of the recipients of the TD Ready Challenge grant to help support the upcoming organoid facility. Read the story »
Milestone reached in new leukemia drug 11/19/2019 Salt-Inducible Kinase 3 (SIK3) could be a good therapeutic candidate for treating MLL translocation positive subtype of leukemia. Read the story »
How a lab and its model animals changed science 8/13/2019 The natural history of science at Cold Spring Harbor Laboratory through the lens of animal research. Read the story »
Sugars that coat proteins are a possible drug target for pancreatitis 6/20/2019 CA19-9, a complex sugar structure coating proteins, represents a possible drug target for treatment of pancreatitis and prevention of pancreatic cancer. Read the story »
Fighting cancer in 3D 6/7/2019 David Tuveson, Director of the CSHL Cancer Center, shares insights about his work on organoid technology. Read the story »
